Emmaus Life Sciences Announces Launch of Full-Service Telehealth Solution

Platform Providers Will Handle On-line Prescribing, Dispensing and Delivery of EndariĀ® TORRANCE, Calif., April 11, 2022 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTQXC: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today...

Click to view original post